Option Care Health Inc Stock Price, News & Analysis

Option Care Health (NASDAQ: OPCH) has announced preliminary financial results for Q3 2021, projecting net revenue between $888 million and $893 million, a 14% increase from the previous year. The expected net income ranges from $33 million to $36 million, while Adjusted EBITDA is anticipated to be between $76 million and $79 million, indicating a growth of 28% to 34% year-over-year. The company reported an operational cash flow of approximately $50 million to $52 million and an ending cash balance of around $200 million as of September 30, 2021. Full results will be released on November 4, 2021.

Option Care Health, Inc. (NASDAQ: OPCH) plans to offer $500 million in senior notes due 2029, subject to market conditions. Concurrently, it will refinance $600 million of its existing first lien term loan facility extending maturity to 2028. The funds will be used to refinance current borrowings and cover fees associated with these transactions. The notes will be unsecured and guaranteed by the company’s domestic subsidiaries. The offering is targeted at qualified institutional buyers and will not be registered under the Securities Act.

Option Care Health (Nasdaq: OPCH) has announced the acquisition of Infinity Infusion Nursing, LLC for $50 million in cash, effective October 1, 2021. This strategic move enhances Option Care Health's home infusion services, expanding its national network of over 2,900 clinicians and now incorporating Infinity’s 1,300 specialty nurses across 49 states. The acquisition is aimed at improving patient care through enhanced clinical resources and technology, while Infinity will operate as a separate entity under its founding leadership.

Option Care Health (NASDAQ: OPCH) announced that Madison Dearborn Partners will sell 9.2 million shares of its common stock at $26.90 each in a public offering, expected to close on September 9, 2021. This sale represents approximately 5.1% of the company's outstanding shares, reducing Madison Dearborn's ownership from 26.2% to 21.1%. The company will not receive any proceeds from this offering. Goldman Sachs & Co. LLC is the sole underwriter, and the offering is registered with the SEC. Option Care Health is the largest independent provider of home infusion services in the U.S.

Option Care Health (NASDAQ: OPCH) announced that an affiliate of Madison Dearborn Partners will sell 9,200,000 shares of its common stock in an underwritten public offering. This sale accounts for approximately 5.1% of the total shares outstanding, reducing the Selling Stockholder's ownership from 26.2% to 21.1%.

Goldman Sachs is the sole underwriter for the offering, and the company will not receive any proceeds. The offering follows a previous secondary offering in August 2021, with Walgreens intending to maintain its 21% indirect interest in the company after this offering.

Option Care Health announced a public offering of 18 million shares at $20.25 each, increasing from the original 15 million shares. This represents approximately 10% of total shares outstanding, and the underwriters have a 30-day option for an additional 2.7 million shares. Following the offering, the Selling Stockholder's ownership will drop from 37.7% to 27.7%. The offering is scheduled to close on August 5, 2021. Option Care Health will not receive any proceeds from this sale.

Option Care Health has announced a public offering of 15 million shares of common stock by an affiliate of Madison Dearborn Partners, with an additional option for underwriters to purchase 2.25 million more shares. This represents approximately 8.3% of outstanding shares, reducing the Selling Stockholder's interest from 37.7% to 29.3%. The offering proceeds will benefit equity holders of the Selling Stockholder, including Walgreens, which will maintain a 21% indirect financial interest post-offering. Goldman Sachs is the sole underwriter for this transaction.

Option Care Health, the largest independent provider of home and alternate site infusion services, reported strong financial results for Q2 2021. Net revenue reached $860.3 million, a 16.1% increase year-over-year. Gross profit rose to $199.0 million, equating to 23.1% of net revenue, with net income of $31.8 million or $0.18 per share, marking a turnaround from a net loss in Q2 2020. Adjusted EBITDA grew by 33.3% to $72.8 million, and cash flow from operations improved to $73.7 million. The company also completed an acquisition of BioCure's assets for $18.9 million.

Option Care Health (Nasdaq: OPCH) has appointed Dr. Seema Kumbhat as its new Chief Medical Officer. In her role, she will oversee clinical strategies, operations, quality improvement, and regulatory compliance. Dr. Kumbhat has a strong background, previously serving as Senior Vice President and Regional Medical Officer at Fresenius Kabi, and has held positions at major healthcare organizations. CEO John Rademacher expressed confidence in her ability to enhance patient care and clinical outcomes as the company continues to differentiate its infusion services.